Counter-regulatory ‘Renin-Angiotensin’ System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients - Archive ouverte HAL Access content directly
Journal Articles Infectious Disorders - Drug Targets Year : 2020

Counter-regulatory ‘Renin-Angiotensin’ System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients

Cédric Annweiler
Zhijian Cao
  • Function : Author
Yingliang Wu
  • Function : Author
Emmanuelle Faucon
  • Function : Author
Stéphanie Mouhat
  • Function : Author
Hervé O Kovacic
Institut de neurophysiopathologie
Jean-Marc Sabatier
Institut de neurophysiopathologie

Domains

Life Sciences [q-bio] Microbiology and Parasitology Virology Life Sciences [q-bio] Biochemistry, Molecular Biology

Ludovic Leloup  : Connect in order to contact the contributor

https://hal-amu.archives-ouvertes.fr/hal-03357854

Submitted on : Wednesday, September 29, 2021-9:27:00 AM

Last modification on : Wednesday, February 8, 2023-5:11:19 PM

Not file

Dates and versions

hal-03357854 , version 1 (29-09-2021)

Identifiers

Cite

Cédric Annweiler, Zhijian Cao, Yingliang Wu, Emmanuelle Faucon, Stéphanie Mouhat, et al.. Counter-regulatory ‘Renin-Angiotensin’ System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients. Infectious Disorders - Drug Targets, 2020, 20 (4), pp.407-408. ⟨10.2174/1871526520666200518073329⟩. ⟨hal-03357854⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

CNRS UNIV-AMU INP INP-CSNP PHARMA-AMU NEUROMARSEILLE
11 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More